Elucid 2025 Annual Report: Uganda and Côte d’Ivoire Expansion

In Short

Elucid published its 2025 Annual Report in July 2026. The update highlights expansion into Uganda and Côte d’Ivoire. It also reports more than 25,000 additional people enrolled in its healthcare programs.

What Happened

In its 2025 Annual Report, Elucid said it launched operations in Uganda and Côte d’Ivoire. That takes its footprint to six countries across three continents, according to the report.

Elucid said it enrolled over 25,000 additional people into its programs in 2025. These programs are designed to help farming families access healthcare, often linked to agricultural supply chains like cocoa, coffee, and cotton.

The report also says Elucid onboarded 63 healthcare providers and financed more than 24,000 healthcare visits. “Financed visits” means the program helped pay for medical care, similar to an insurance claim but delivered through a partner network.

On partnerships, Elucid listed several new corporate partners. They include The Hershey Company, Sucafina, ETG, JDE Peet's, and Olam Agri. It also said it expanded work with existing partners such as Tony’s Chocolonely, Touton, and Max Felchlin AG.

Beyond company partnerships, Elucid cited institutional co-funders including UBS Optimus Foundation, Bayer Foundation, GIZ, and DEG Impulse. It also highlighted work with Gavi, the Vaccine Alliance to support vaccination campaigns in Côte d’Ivoire and Ghana, reaching over 210,000 children.

Why It Matters

For agribusinesses, farmer health is increasingly treated as a supply chain risk issue, not only a social impact project. When rural households can access treatment for illnesses like malaria or bronchitis, farms lose fewer workdays and buyers can reduce sourcing volatility.

For African health delivery, Elucid’s model leans on provider networks, mobile clinics, and quality of care support. These are practical building blocks in places where public clinics are far away or under-resourced.

For founders and operators, the report is also a signal about how corporate-funded healthcare programs are scaling. More multinational buyers are willing to co-fund services in origin communities, especially in cocoa and coffee regions across West and East Africa.